The genetic effect on omega 3 fatty acid supplementation for the treatment of non alcoholic fatty liver disease in obese children and adolescents
Diseases and Conditions Researched
Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1; Hypertriglyceridemia; Non Alcoholic Fatty Liver Disease; Steatohepatitis
What is the purpose of this trial?
To explore whether there is a different response to the omega-3 fatty acid supplementation vs omega-3 fatty acid rich diet with respect to the hepatic fat fraction % (HFF), triglyceride, and ALT levels between the rs738409 minor allele (GG) and the common allele homozygous (CC) of PNPLA3.
Click here for detailed participation information for this trial.
|Sponsor:||Yale University School of Medicine|
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.